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THE GENERALIZED EFFECT OF BMP-2 ON OXIDATIVE 
PHOSPHORYLATION  
KATHERINE ELIZABETH SEXTON 
ABSTRACT 
Bone Morphogenetic Proteins (BMPs) belong to the Transforming Growth Factor 
Beta superfamily of growth factors. While BMP signaling has been shown to induce 
skeletogenic differentiation of mesenchymal stem cells and be involved in the formation 
of ectopic bone and ossification, BMPs also are involved in the differentiation of many 
other tissues including neurogenic tissues.  Prior studies from our laboratory showed that 
BMP-2 induction of chondrogenic differentiation of the C3H10T1/2 murine 
mesenchymal stem cell line was associated with increased oxidative metabolism.  This 
study was performed to test the hypothesis that BMP-2 promotes increased oxidative 
metabolism during the differentiation of other types of cells. Using the neurogenic cell 
line, SH-SY5Y, this study examined whether cellular differentiation induced by BMP-2 
also was associated with increased oxidative phosphorylation in non-mesenchymal stem 
cells.  
SH-SY5Y cells were grown in growth medium (DMEM/F12 with 10% FBS, 1% 
Penicillin/Streptomycin, L-glutamine, and non-essential amino acids).  Cells were plated 
appropriately at differing seeding densities (Day 0), treated one time with ± 200ng/mL 
BMP-2 two days after plating and analyzed on Day 4.  Oxidative metabolism was 
measured using a Seahorse XF Analyzer that measures oxygen consumption rate (OCR) 
and extracellular acidification rate (ECAR).  BMP-2 induction of neural cell 
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differentiation was assayed by quantifying dendrite communication between neurons and 
decreased proliferative capacity as assessed by overall culture DNA contents. 
Mitochondrial density after BMP-2 treatment was examined using vital mitochondrial 
labeling.  
Groups treated with BMP-2 contained significantly less DNA content than control 
groups (p=0.006). BMP-2 treated cells had on average more dendritic interactions with 
one or two and more processes than control groups (p=0.396; p=0.872), while there were 
a larger percentage of cells not treated with BMP-2 that had zero dendritic interactions 
(p=0.470). All parameters of oxidative metabolism were increased in cells treated with 
BMP-2. More specifically, basal respiration and ATP production were significantly 
increased in BMP-2 treated cells (p=0.031; p=0.010).  
SH-SY5Y cells were significantly affected by BMP-2 treatment in both DNA 
content and oxidative phosphorylation.  The diminished DNA content with BMP-2 
treatment is consistent with the known decrease in cellular proliferation that is associated 
with neural cell differentiation. While there were small increases in dendritic interactions 
these were not significant and are inclusive for demonstrating BMP-2’s effect on neural 
differentiation.  Upregulation of oxidative phosphorylation indicated after BMP-2 
treatment was validated by the substantial increases in metabolic parameters associated 
with BMP-2 treatment. Through the utilization of the neural cell line, SH-SY5Y, this 
research suggests a more generalized functionality of BMP-2 in upregulation of oxidative 
metabolism as well as differentiation non-specific to bone and chondrocyte cell lineage. 
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INRODUCTION 
 
Bone Morphogenetic Protein (BMP) 
Bone Morphogenetic Proteins (BMPs) comprise a group of growth factors of the 
Transforming Growth Factor Beta (TGFß) superfamily (Bragdon et al. 2011). Though 
originally identified in the development of bone and cartilage, BMPs have been 
recognized to have a wide variety of functions involving cell apoptosis, proliferation, 
differentiation, and morphogenesis in a range of cell types (Hogan 1996).  
There are about 20 types of BMPs identified, functioning anywhere from skeletal 
regeneration and repair to limb development to even spermatogenesis and oocyte 
development (Bragdon et al. 2011). Many of the compounds from the BMP family have 
been identified as necessary for life (Zhang and Bradley 1996). Lack of BMP-2 and 
BMP-4, for example, are lethal to embryo development while other types of BMP 
knockouts result in deformities or defects in organ function (Carreira et al. 2014).    
Structurally, BMPs are synthesized as large inactive precursors consisting of an 
N-terminal signal peptide, a domain to ensure proper folding, and a C-terminal mature 
peptide (Carreira et al. 2014) (Figure 1). Following cleavage, most BMPs dimerize to 
form a final disulfide-linked active protein (Bragdon et al. 2011). Succeeding 
dimerization, BMPs bind to BMP receptors (BMPRs) initiating an intracellular signal and 
culminating in effecting target genes (Bragdon et al. 2011).  
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Figure 1. Structural changes during BMP activation. BMPs start as inactive full-
length preproproteins with three sites: An N-terminal signal sequence, a propeptide 
required for folding and dimerization and a C-terminal mature region. Following 
dimerization, the intermediate BMP molecule is cleaved into an active BMP dimer. 
(Adapted from Carreira et al. 2014). 
 
There are two types of BMPRs, type I and type II (Bragdon et al. 2011). There are 
five identified BMPRIs: ALK1 (Acvrl1), ALK2 (ActRI), ALK3 (BRIa), ALK4 (ActRIb) 
and three identified BMPRIIs: BRII, ActRIIa, and ActRIIb. (Bragdon et al. 2011).  
BMPRs are transmembrane serine-threonine kinase receptors in which, upon BMP ligand 
binding, the constitutively active type II receptor kinase transphosphorylates the type I 
receptor (Carreira et al. 2014) (Figure 2). Binding to the extracellular surface of cells 
	3 
through BMPRs, BMPs operate in two signaling pathways: a canonical and a non-
canonical pathway (Bragdon et al. 2011). The canonical pathway, or the Smad-dependent 
pathway, involves the activation of Smad proteins. When an active BMP molecule binds 
the extracellular BMP receptor and BMPRII’s constitutively active kinase 
transphosphorylates BMPRI, the BMPRI recruits a series of proteins known as the 
Regulatory Smads (R-Smads) (Carriera et al. 2014). Following activation of R-Smads, 
most commonly, Smads 1, 5, and 8, Co-Smads, such as Smad 4, is activated resulting in 
both the R-Smads (Smads 1, 5, and 8) with the Co-Smad (Smad 4) translocated into the 
nucleus, consequentially leading to regulation of transcription. On the other hand, the 
non-canonical pathway, or the Smad-independent pathway, involves the activation of the 
mitogen-activated protein kinase (MAPK) pathway. After the binding of BMP and the 
transphosphorylation of BMPRII to BMPRI, the MAPK pathway may be activated 
resulting in the activation of extracellular signal-regulated kinase (ERK), C-jun N-
terminal kinase (JNK), map kinase p38 (p38 MAPK), or nuclear factor kappa beta 
(NFkB) and effecting gene transcription; however, this signaling pathway is less clear 
than the canonical pathway (Bragdon et al. 2011) (Figure 2). 
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Figure 2. BMP receptor activation and signaling pathway. Due to ligand binding, 
BMPRs dimerize and the phosphorylation of BMPRII binds to BMPRI. After protein-
protein interactions between receptors, BMP either induces the non-canonical pathway 
resulting in the MAPK pathway or the canonical pathway resulting in phosphorylation of 
R-Smads (Smads 1, 5, and 8) with co-Smad (Smad 4). Both pathways effect regulation of 
transcription. (Adapted from Ampuja and Kallioniemi 2019).  
 
BMP-2’s Initial Function in Bone   
As one of the most studied BMPs, Bone Morphogenetic Protein-2 (BMP-2), was 
originally found to be a major signaling factor in skeletal growth, specifically in the 
formation of ectopic bone and ossification (Wozney et al. 1988). In regard to bone 
development, BMP-2 is considered to be essential for chondrocyte proliferation and 
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endochondral bone, bone developing from cartilage utilized in the development of the 
majority of the human skeleton (Wang et al. 2014). Cho, Gerstenfeld, and Einhorn (2002) 
showed that BMP-2 is continually present from the beginning stages of fracture repair 
until three weeks into repair and that it acts as a signaling molecule inducing other BMPs 
including BMP-3 and BMP-4. Moreover, BMP-2 has been found to play a role in 
differentiation, not recruitment, of mesenchymal stem cells (MSCs), which are necessary 
for healing of bone injury (Tsuji et al. 2006). Wang et al. (1993) experimented with a 
mesenchymal cell line, C3H10T1/2 cell line, and found that MSCs differentiated into fat, 
cartilage and bone in the presence of a conditioned amount of BMP-2, with higher 
concentrations promoting bone and cartilage formation and lower concentrations 
stimulating adipogenesis. Although extensive research has been conducted on BMP-2 
within osteogenic cell lines, its effects on additional cell lines is less well known.  
 
BMP-2 Function Independent of Bone and Cartilage Development  
Beyond BMP-2’s importance in bone and cartilage development, it has been 
demonstrated to have properties extending to the cardiovascular system as well as having 
effects in neural tissue. Zhang and Bradley (1996) experimented with BMP-2 deficient 
mice showing that amnion and chorion development was hindered as well as embryos 
possessing cardiac defects, suggesting that BMP-2 is essential for embryogenesis, 
specifically for mesoderm and cardiac formation. In addition to mesodermal 
development, BMP-2 appeared to have a more generalized role in neural differentiation. 
Yan et al. (2016) experimented with BMP-2 in a neural stem cell line and found that by 
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assessing expression factors of dopaminergic neurons, in vitro BMP-2 promoted the 
differentiation of neural stem cells (NSCs) into dopaminergic neurons. Hegarty et al. 
(2013) also conducted neural research on BMP-2 using a SH-SY5Y neuroblastoma cell 
line, displaying that BMP-2 induced differentiation of the cells as well as increased the 
total length of dendrites, but not necessarily the number of cells. From this research, 
BMP-2 may have potential that goes beyond bone development and repair; however, 
more research must be conducted to find consistency among investigators.  
 
Neurogenesis and Associated Metabolic Changes 
Adult neurogenesis involves a stepwise developmental process starting with 
activation of quiescent neural stem cells (NSCs) dividing to generate intermediate 
progenitor cells (IPCs) eventually giving rise to committed neuroblasts (NBs) which then 
migrate to appropriate location based specific signaling pathways (Beckervordersandforth 
et al. 2017) (Figure 3). With transitions from the basis of neurogenesis to a well-
differentiated neuron, energy requirements as well as metabolic processes change 
allowing appropriate growth of each cell type in the development process.  
Quiescent NSCs rely on glycolysis for metabolic needs (Folmes and Terzic 2016). 
Thought to be due to the lower energy demands of a quiescent stem cell, a reliance on 
glycolysis is hypothesized to limit oxidative metabolism generation of reactive oxygen 
species (ROS), therefore reducing the cellular damage caused by ROS 
(Beckervordersandforth et al. 2017). Zheng et al. (2016) experimented with enzyme 
levels known to be directly involved in glycolysis, hexokinase and lactate dehydrogenase 
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A, and showed that in a comparison between NSCs and neurons, hexokinase and lactate 
dehydrogenase A were readily detected in NSCs but not in neurons. These results 
displayed that glycolysis, not oxidative phosphorylation, may be a larger contributing 
factor in quiescent NSC metabolism. Beckervordersandforth et al. (2017) additionally 
investigated deleting mitochondrial transcription factors in order to disrupt electron 
transport and oxidative phosphorylation in NSCs. The deletion had no influence on the 
number NSCs; however, it did effect the proliferation of NSCs to IPCs, proposing that 
NSCs also survive off mechanisms outside of the mitochondria and that proliferation and 
possibly differentiation require alternate energy production mechanisms 
(Beckervordersandforth et al. 2017). In combination with enzyme research, Sun et al. 
(2016) displayed that glycolysis-dependent stem cells frequently exhibit immature 
mitochondrial infrastructure, inadequately developed cristae and low amounts of 
mitochondrial DNA. Such results suggest that immature mitochondrial development is 
correlated to a less differentiated state that is reliant on non-aerobic metabolic processes 
outside of the mitochondria.  
While quiescent NSC’s depend on glycolysis for energy, actively proliferating 
and differentiating neuron cells rely heavily on mitochondrial oxidative phosphorylation 
(Zheng et al. 2016). In actively differentiating NSCs there is upregulation in electron 
transport chain activity and oxidative phosphorylation as well as a downregulation in 
glycolytic enzymes (Beckervordersandforth et al. 2017). Beckervordersandforth et al. 
(2017) displayed that when NSCs are activated, genes for ATP synthase (Complex V), 
which is responsible for synthesis of ATP through oxidative phosphorylation in the 
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mitochondria, are upregulated. Furthermore, mitochondrial characteristics such as mass, 
density and upregulation of activity were also apparent in metabolic changes in 
neurogenesis. Moyes et al. (1997) demonstrated that during cellular differentiation, 
mitochondrial mass increased. In addition, Cheng, Hou and Mattson (2010) expressed 
that differentiation in neurons through neurogenesis resulted in increased mitochondrial 
DNA, electron transport chain capacity and increased the activity of NADH-generating 
proteins.   
In addition to upregulation of oxidative phosphorylation, active and proliferating 
neural stem cells and progenitor cells appear to also participate in lipid biosynthesis 
(Folmes and Terzic 2016). Knobloch et al. (2013) experimented with neural stem cells 
and progenitor cells displaying that rate limiting enzyme of fatty acid synthesis, fatty acid 
synthase (FAS), is expressed in active neurogenic regions of NSCs and IPCs, suggesting 
the involvement of lipid biosynthesis is required for the generation of lipid membranes in 
cell division during neurogenesis.  Furthermore, Knobloch et al. (2013) presented that, 
with a FAS deletion or inhibition, NSC and IPC proliferation is impaired, resulting in less 
newly created neurons. Consequently, neurons seem to be unique in the fact of reliance 
on both glycolysis and lipid biosynthesis for proliferation.  
While most research has been done on metabolic changes between NSCs 
differentiation to later cell types, progenitor neural cells differentiation to non-dividing 
neurons have also displayed metabolic changes. Agathocleous et al. (2012) experimented 
with embryonic frog Xenopus	retinas in vivo and showed that proliferating cells use 
aerobic glycolysis for energy production, while non-dividing differentiated cells depend 
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more on ATP production in the form of oxidative phosphorylation, suggesting that the 
switch in form of energy production is coupled to neuronal differentiation. Using human 
neural progenitor cells, Zheng et al. (2016) also presented that the loss of two metabolic 
enzymes in glycolysis, hexokinase and lactate dehydrogenase, influence the change of 
energy production type resulting in the transition from aerobic glycolysis to oxidative 
phosphorylation. From this research, it seems that actively proliferating and 
differentiating cells result in a change in mechanisms of cellular energy production.  
 
Figure 3.  Mitochondrial metabolism changes throughout adult Neurogenesis. 
Neural stems cells (NSCs) proliferate into intermediate progenitor cells (IPCs). IPCs 
differentiate into neuroblasts (NBs) which give rise to mature neurons. Proliferation of 
NSCs into mature neurons is associated with changes in mitochondrial metabolism from 
glycolysis and fatty acid oxidation based metabolism to a metabolism function more 
through oxidative phosphorylation in more mature neurons. (Adapted from 
Beckervordersandforth et al 2017.) 
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Assessing Metabolic Changes in Research  
In order to assess these changes in metabolic activity and quantitatively analyze 
oxidative phosphorylation properties, the Seahorse Extracellular Flux Mitochondrial 
Stress Test (Seahorse XF Test) has often been used as a tool in research. The Seahorse 
XF Test measures mitochondrial function by mixing known quantities of oxygen with 
cell cultures and in accordance measuring associated pH changes (Figure 4). In doing so, 
a series of inhibitors to oxidative phosphorylation are injected into the medium and 
resulting changes in oxygen consumption rate (OCR) are measured. Following OCR 
measurement, changes between application of the different inhibitors allows for 
calculation of basal OCR, maximal OCR and oxygen consumed during ATP synthesis.  
 
Figure 4. Oxidative Phosphorylation pathway. Mitochondria establish a proton 
gradient through a series of oxidation steps along the inner mitochondrial membrane. 
Complexes I, III and IV participate in the pumping of protons establishing a gradient to 
allow coupling between the transfer of protons across the membrane with 
phosphorylation of ADP. Using the electrochemical gradient formed from proton 
pumping, ATP synthase (Complex V) synthesizes ATP from phosphorylating adenosine 
monophosphate and adenosine diphosphate (ADP). (From Lippincott’s Biochemistry, 5th 
edition).  
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Throughout the Seahorse XF Stress Test, certain inhibitors of oxidative 
phosphorylation allow for more thorough measurement of changes in oxygen 
consumption rate (Figure 5). Initially, basal rate is measured. Following baseline 
measurement, oligomycin, an inhibitor of the F0 subunit of ATP synthase is injected into 
the cell culture plate (Figure 5). The resulting difference between the basal respiration 
and the oligomycin-injected OCR is defined as the amount of the OCR that is devoted 
toward ATP production in the cells. The OCR level at which the post-oligomycin 
injection is denoted as the measurement of the proton leak. Next, carbonyl cyanide-p-
(trifluoromethocy)phenylhydrazone (FCCP) is injected decoupling ATP synthase from 
the proton gradient and disrupting the inner mitochondrial matrix resulting in the measure 
of maximal respiration (Figure 5). Antimycin A is injected last and prevents proton 
gradient formation by inhibiting Complex III of the electron transport chain (Figure 5).  
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Figure 5. Diagrammatic display of inhibitors and measurements of oxygen 
consumption rate (OCR). Inhibitors of the electron transport chain used (A). Oxygen 
consumption rate (OCR) was measured using the Seahorse XF 96 Extracellular Flux 
Mitochondrial Stress Test (B). Basal respiration was first established. Following basal 
rate measurement, Oligomycin, an inhibitor of the F0 subunit of ATP synthase, was 
injected. Oligomycin injection allowed for both the measurement of the proton leak as 
well as measuring the ATP production by calculating the difference between the basal 
OCR and the post-oligomycin OCR. FCCP, an uncoupling agent, was then injected. This 
allowed for assessment of maximal respiratory capacity. Lastly, antimycin A, an inhibitor 
of Complex III of the electron transport chain was injected resulting in inhibition of all 
oxidative phosphorylation. OCR post-antimycin A injection is attributed to non-
mitochondrial respiration. (Adapted from Seahorse Bioscience XF Stress Test Report 
Generator User Guide and Blank 2017).  
 
A	
B	
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Several studies have used the Seahorse XF Stress test to examine the effects of 
BMP-2 on metabolic changes in different cell types. Wang et al. (2018) investigated 
metabolic changes in human articular chondrocytes (ACs) when induced with 
Transforming Growth Factor-ß1 (TGF- ß1) and BMP-2 from osteoarthritic (OA) patients. 
Articular chondrocytes were collected from residual full thickness and intact cartilage of 
the femoral condyle in OA patients and were treated with a control, TGF- ß1 or a BMP-2 
dose for 48-72 hours following collection. The investigators analyzed the metabolic 
profiles of the BMP-2 induced ACs, displaying that BMP-2 did not show any significant 
effects in glucose consumption and there were reduced lactate levels. Additionally, the 
experimenters noted that with BMP-2 treated ACs, there was increased ATP production, 
suggesting BMP-2 enhances and possibly directs metabolism to a more oxidative process. 
Following initial experiments, mitochondrial Seahorse XF stress testing was then 
performed. BMP-2 induced ACs had significantly elevated oxygen consumption rates, 
compared to the control, again suggesting that BMP-2 upregulates oxidative 
phosphorylation (Wang et al. 2018).  
Chandrasekaran et al. (2015) examined the metabolic effects of BMP-7 as well as 
researching the dendritic growth of BMP-2 induction on cultured rate sympathetic 
neurons. Researchers experimented with a submaximal dosing of BMP-2 at 10 ng/mL as 
well as a treatment of BMP-7 at 50 ng/mL in a different experimental group. Both 
experimental groups resulted in an increase in the number of dendrites per cell when 
induced, suggesting that BMPs have a differentiating effect in neural cell lines. 
Additionally, the researchers were interested in the metabolic effects of BMP-7. When 
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sympathetic neurons were induced with the treatment of 50 ng/mL of BMP-7, 48 hours 
after treatment, the neurons had increased oxygen consumption rate compared to control 
cells, suggesting BMPs role in metabolic changes or an upregulation of oxidative 
phosphorylation (Chandrasekaran et al. 2015).  While BMP-7 was used in this study, 
more research needs to be conducted on how BMP-2 influences cellular metabolism and 
may have an effect in upregulation in oxidative phosphorylation. 
 
Study Goals  
Prior studies showed that BMP-2 induction of chondrogenic differentiation of the 
C3H10T1/2 murine mesenchymal stem cell line was associated with increased oxidative 
metabolism.  This study was performed to test the hypothesis that BMP-2 promotes 
increased oxidative metabolism during the differentiation of other types of stem cells. 
Using the neurogenic cell line, SH-SY5Y, this study examined whether cellular 
differentiation induced by BMP-2 also was associated with increased oxidative 
phosphorylation in non-mesenchymal stem cells. Oxidative metabolism was measured 
using a Seahorse XF Analyzer that measures oxygen consumption rate (OCR) and 
extracellular acidification rate (ECAR).  BMP-2 induction of neural cell differentiation 
was assayed by quantifying dendrite communication between neurons and decreased 
proliferative capacity as assessed by overall culture DNA contents. Other studies 
examined mitochondrial density after BMP-2 treatment using vital mitochondrial 
labeling.  
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Specific Aims  
The goals of this study were:  
1. To measure oxidative consumption rate with induction of BMP-2 in the SH-
SY5Y neural cell line.  
2. To assess dendrite communication and DNA contents in the SH-SY5Y neural 
cell line cultures treated with BMP-2.  
3. To qualitatively assess mitochondrial density after BMP-2 treatment in the 
SH-SY5Y neural cell line cultures (Redmann et al. 2018).  
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METHODS 
 
Cell Culture  
SH-SY5Y neuron cell line was used for the following experimental studies. The 
SH-SY5Y cell line was grown in a growth medium consisting of Dulbecco’s Modified 
Eagle Medium Ham’s F-12 (DMEM/F12) (Lonza, Walkersville, MD) with 10% fetal 
bovine serum (Atlanta Biologicals, Inc., Flowery Branch, GA), 1% 
penicillin/streptomycin antibiotic (Life Technologies Corporation, Grand Island, NY) 
1%MEM non-essential amino acids (Life technologies corporation, Grand Island, NY) 
and 1% L-glutamine (Mediatech Inc., Herndon, VA) in a humidified incubator (37° C, 
5% CO2). For experiments on dendrite and mitochondria quantification and 
identification, cells were seeded at a density of 7,500 cells per well on Lab-Tek 4 Well 
Chamber Slides (System 177437).  
For Seahorse 96 XF Mitochondrial Stress Test, pilot experiments were performed 
testing a variety of cell densities to assess proper density allowing for both quantification 
of metabolic activity as well as DNA quantification. Trials included densities of 1x103, 
2x103, 4x103, 8x103, and 1.6x104. For all experiments, cells were given 2 days in growth 
medium after seeding on respective plates before addition of BMP-2. Day 0 was defined 
as the day in which the cells were plated, while Day 2 was defined as two days post- 
seeding procedure. When analyzing the effects of BMP-2, cells were treated with          
+/- 200ng/mL BMP-2 (Research and Diagnostic Systems, Inc., Minneapolis, MN) 
supplemented media on Day 2 to appropriate experimental groups. On Day 4, cells were 
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collected and analyzed for subsequent experiments to be performed or another treatment 
with +/- 200ng/mL BMP-2 (Research and Diagnostic Systems, Inc., Minneapolis, MN) 
supplemented media if required. Pilot studies were performed at Day 4 and Day 6 to 
analyze BMP-2 effects on SH-SY5Y cell growth and differentiation and to assess 
parameters for future experiments. As determined by preliminary data collection and 
analysis, there was extensive growth and replication of the SH-SY5Y cell line for 
dendrite quantification and analysis, and thus Day 4 was chosen for assays involving 
DNA content quantification, fluorescent imaging, and metabolic assays.  
Table 1. Timeline of cell culture and experimental methods. Cells were plated on Day 
0. BMP-2 was given to experimental groups on Day 2. Appropriate quantitative or 
qualitative assays were completed on Day 4. 
 
 
 
 
 
DNA Extraction and Quantification  
DNA was extracted from each culture cell well using an extraction buffer 
containing 4M guanidine (Sigma-Aldrich Inc, Saint Louis, MO) and 1% Triton X-100 in 
1X TE. Using 250 µL of extraction buffer, DNA was transferred to 1.5 mL 
microcentrifuge tubes. Following well extraction, each DNA sample was diluted with 
Time (Day) Procedure 
Day 0 Plating of SH-SY5Y cells on respective plates 
Day 2 200ng/mL of BMP-2 in media given to appropriate experimental groups 
Day 4 Quantitative or qualitative experimental assays completed  
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250 µL ultra-filtrate DNase-free water and stored at -80°C until quantification was 
performed.  
Relative DNA quantification was performed using Quant-it PicoGreen dsDNA 
Assay Kits (Thermo Fisher Scientific, Waltham, MA). Seahorse 96XF plates were 
quantified based on the manufacturer’s directions. Using a BioTek Synergy 2 Multi-mode 
Microplate Reader, excitation and emission were measured. Excitation was measured at a 
wavelength of 485 nm with bandwidth of 20 nm, while emission was measured at a 
wavelength of 530 nm and bandwidth of 25 nm. Using a standard curve, the DNA 
concentration of each well was calculated based off the PicoGreen intensity. 
 
Dendrite Identification and Quantification  
 Identification of dendritic processes was performed using Phalloidin from Aminta 
phalloides (Sigma-Aldrich, St. Louis, MO). Staining reactions with Phalloidin were based 
on the procedure as per the manufacture. For these studies cells were grown in Lab Tek 4 
chambers slides. Prior to staining, cells were fixed using formaldehyde at a 3.7% and 
permeabilized using 0.1% Triton X-100 in PBS. Cells were stained at a concentration of 
50µg/mL of fluorescent Phalloidin conjugate solution in PBS. After room temperature 
incubation, DAPI and mounting media were used to cover slip the slides. Cells were 
observed using fluorescence at an excitement of 493 nm and emission of 517 nm for 
Phalloidin staining and at an excitement of 360 nm and emission of 460 nm for DAPI 
staining.  
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 Once fluorescence was established, quantification was performed by first using 
Photoshop CC to overlay fluorescent Phalloidin and DAPI images. To allow for a more 
time-efficient quantification of dendrites and dendrite communication, each well on the 
Lab Tek slides were gridded, numbered and randomly assigned resulting in assessment of 
approximately 5% of each well. Parallel box numbers were used for both experimental 
and control slides.  
 
Mitochondrial Visualization with Nuclear Staining  
 Mitochondrial visualization was performed using Abcam’s CytoPainter MitoRed 
Indicator Reagent (MitoRed) to fluorescently label mitochondria in live cells. MitoRed 
was warmed to room temperature and a working dye solution was prepared using 20 µL 
of MitoRed Reagent in 10 mL of SH-SY5Y growth media. Cells were washed prior to the 
addition of working dye solution with PBS. Once dye was added to the wells, cells were 
incubated for one hour in a 37°C, 5% CO2 incubator. Following incubation time, SH-
SY5Y cells were placed back into media to maintain proper functionality and health of 
cells. Cells were observed using fluorescence at an excitation of 575 nm and emission of 
600 nm.  
Following mitochondrial staining, cell nuclei were stained using Hoechst dye 
stock solution. Hoescht staining solution was diluted using SH-SY5Y cell media at a ratio 
of 4:1,000. Cells were incubated and protected from light for 10 minutes. After removing 
the dye and washing with PBS, cells were imaged at an excitation of 350 nm and an 
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emission of 461 nm (DAPI standard filter set) at 20x magnification. Once fluorescence 
was established, quantification was performed by first using Photoshop CC to overlay 
fluorescent MitoRed and Hoechst stained images. Qualitative analysis of mitochondria in 
relation to nuclei positioning followed.  
 
Oxygen Consumption Rate Quantification  
 Four days after plating the SH-SY5Y cells, oxygen consumption rate was 
assessed using the Seahorse 96 XF mitochondrial stress test. Cells were grown on 
Seahorse culture 96 well plates and growth media was used until the day of assay. The 
BMP-2 induction protocol was followed as previously described.  Prior to oxygen 
consumption rate quantification, growth media was aspirated and each well was washed 
with Seahorse XF Assay Medium. Seahorse XF Assay Medium (Seahorse Bioscience 
Inc., North Billerica, MA) with the addition of 20 mM D-glucose (VWR International, 
Rador, PA), 4 mM L-glutamine (Life Technologies, Beverly, MA), and 5 mM sodium 
pyruvate (Life Technologies, Beverly, MA) was used to fill each well for quantification. 
The pH was adjusted to 7.4 and incubated at 37°C without CO2 for a minimum of 45 
minutes.  
Prior to Seahorse measurement, the injection cartridge was hydrated with 
Seahorse Calibrant (Seahorse Bioscience Inc., North Billerica, MA) and incubated 
twenty-four hours prior in 37oC with no CO2. Oxygen consumption was measured using 
three inhibitors of oxidative phosphorylation: oligomycin (EMD Millipore, Billerica, 
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MA), carbonyl cyanide-p-(trifluoromethocy)phenylhydrazone (FCCP) (Sigma-Aldrich 
Inc, Saint Louis, MO), and antimycin A (Enzo Life Sciences Inc, Farmingdale, NY). 
Oligomycin inhibits ATP synthase (Complex V in the electron transport chain) and 
decreases the oxygen consumption rate resulting in a quantifiable measurement of 
mitochondrial respiration associated with cellular ATP production. FCCP functions as an 
uncoupling agent which break downs the proton gradient, disrupting the mitochondrial 
membrane resulting in uninhibited electron flow through the electron transport chain 
where oxygen is maximally consumed. Antimycin A, an inhibitor of Complex III in the 
electron transport chain, inhibiting the formation of the proton gradient in the cell. All 
inhibitors were combined with supplemental XF Assay Medium to form appropriate 
concentrations: 4 uM oligomycin, 2.5 uM FCCP, and 3 uM antimycin A. Each inhibitor 
was loaded into the correct injection port at a volume of 25 uL. Cell culture media was 
aspirated from the culture plate, washed two times with Seahorse XF Assay Medium and 
finished with 175 uL of Seahorse XF Assay Medium.  
After initialization in the Seahorse machine, basal OCR preceded. Basal OCR was 
measured first four times each at 1.5 minutes separated by a 5-minute mix and 30-second 
wait. Then oligomycin was injected in order to determine oxygen consumption from the 
proton leak. This was measured at three cycles of 3.5-minute mix, 3-second wait, and 2-
minute measure for three cycles. Following injection of oligomycin, FCCP was injected 
to measure maximal respiration rate. This was measured at 5.5-minute mix, 1.5-minute 
measure for three cycles. Lastly, antimycin A was injected to assess non-mitochondrial 
respiration contributing to oxygen consumption. This was measured at 4-minute mix, 30- 
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second wait, 2.5-minute measure for three cycles. Oxygen consumption measures were 
calculated according to the Seahorse Bioscience XF Stress Test Report Generator Guide 
(Table 2). Following base Seahorse data measurements, all oxygen consumption rate 
values were normalized to well DNA content through PicoGreen DNA quantification 
assay.  
Table 2. Oxygen consumption rate (OCR) calculations. Calculation for oxygen 
consumption rate following normalization based off DNA content. (Adapted from 
Seahorse Bioscience XF Stress Test Report Generator User Guide and Blank 2017).  
Parameter Rate Measurement Calculation 
Non-Mitochondrial 
Respiration 
Minimum rate measurement after Antimycin A injection  
Basal Respiration  (Final rate measurement before Oligomycin injection) - 
(Non-Mitochondrial Respiration) 
Maximal 
Respiration  
(Maximum rate measurement after FCCP injection) - (Non-
Mitochondrial Respiration) 
H+ (Proton) Leak  (Minimum rate measurement after Oligomycin injection) - 
(Non-Mitochondrial Respiration) 
ATP Production  (Last rate measurement before Oligomycin injection) - 
(Minimum rate measurement after Oligomycin injection) 
Spare Respiratory 
Capacity  
(Maximal Respiration) - (Basal Respiration) 
 
Statistical Analysis 
 Statistical analysis was performed comparing controls and experimental groups in 
an unpaired two sample t-test assuming equal variances. Significance level was assumed 
as p<0.05.  
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RESULTS 
 
Cell Culture Morphology 
Phase-contrast microscopy images of SH-SY5Y cells were taken with growth 
media conditions and induction of BMP-2. Cellular morphology was captured of cell 
cultures using 10x magnification (Figure 6). Treatment with BMP-2 induced neurons 
showed greater dendritic development than those without BMP-2 on Day 4 as well as 
greater number of dendritic connections with other neurons on Day 6 (Figure 6). In terms 
of cell number, the preferred cell growth of neurons around the periphery of wells, also 
appeared to quantitatively distinguish BMP-2 induced neurons from control groups via 
phase-contrast microscopy however these differences were not quantified.   
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 Control BMP-2 
Day 
4 
  
Day 
6 
  
Figure 6. Cell culture morphology images. Phase contrast microscopy photographs 
were obtained of control (BMP-) and experimental (BMP-2) groups at 10x magnification 
at Day 4 and Day 6. Photographs are labeled accordingly with treatment and 
magnification. 
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DNA Content Assessment 
DNA content was assessed using the PicoGreen fluorescent nucleic-acid stain 
(Figure 7). At a plating density of 2 x103, 4 x103, 8 x103 there was no significant 
difference of DNA fluorescence between control and BMP-2 induced neurons. At a 
seeding density of 1.6 x104 cells per well, treatment with BMP-2 significantly decreased 
fluorescence compared to the control (BMP-) group. (p= 0.006) 
Figure 7. Fluorescence of DNA in control cells versus BMP-induced cells over 
different cell densities. Using PicoGreen fluorescent assay, cellular DNA was quantified 
at Day 4 in 4 different well cellular densities. With BMP-2 treatment, DNA content 
indicated by fluorescence was lower than the controls. P-values of each density are listed. 
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Dendrite Interaction Quantification 
 Dendrites were stained via actin staining using Phalloidin and mounted with 
DAPI mounting media for nuclear staining (Figure 8). Following staining, imaging and 
randomization of areas in which to count dendrites, results were analyzed. Following 
counting procedures, means and standard deviations were calculated. While qualitatively 
appearing to be different there was no significant difference in the number of dendritic 
connections between the experimental and control groups; however, on average the 
BMP-2 did have a greater number of interactions per cell (p=0.912). In the experimental 
group (BMP-2) there was an average of 0.384 connections per cell and in the control 
group (BMP-) there was an average of 0.368 connections per cell (Figure 9). Further 
analysis revealed that there was a larger proportion of BMP-2 induced cells which 
appeared to have one connection (p=	0.396)	and	2+	connections	(p= 0.872) while 
control groups appeared to have a	larger proportion of cells with zero interactions (p=	0.470)	(Figure 10). 	
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Control 
 
BMP-2 
 
Figure 8. +/-BMP Dendrite and nuclear stained image. Dendritic staining was 
performed using Phalloidin actin staining and nuclear staining was performed using 
DAPI mounting media. Images were collected at a 10x magnification using appropriate 
fluorescence. Following staining, cells were quantified via manual counting and dendritic 
connections were quantified on a per cell basis.  
100µm 
100µm 
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Figure 9. Average number of interactions per cell in BMP- and BMP+ on Day 4. 
Following growth procedure and dendrite and nuclei staining methods, cells and dendritic 
connections were quantified and analyzed. Groups treated with BMP-2 had a similar 
average number of dendritic connections per cell to groups without BMP (BMP-). P-
value is listed. 
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Figure 10. Percentage of dendritic connections per cell. Cells were either non-treated 
or treated with BMP-2 for 4 days. Cells were fixed, Phalloidin was used to stain actin and 
DAPI was used to stain nuclei. Cells were imaged, grids were added, random images 
were selected, and cell number and number of dendritic connections were recorded.  
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Mitochondrial Visualization 
 Using MitoRed, mitochondria were stained to allow for visualization. In 
conjunction, nuclei were stained using Hoechst dye to allow for consistencies in noting 
the location of mitochondria. In both control and BMP-2 treated groups, mitochondria 
display an encompassing nature around the nuclei (Figure 11).  
Control 
 
BMP-2 
 
Figure 11. Mitochondrial and nuclei staining in experimental (BMP+) and control 
(BMP-) conditions. Mitochondria were stained with MitoRed and nuclei were stained 
with Hoechst dye. Both control and BMP-2 treated groups display a mitochondrial 
circular arrangement near the nucleus. Cells were imaged at 20x magnification.
50	µm	
50	µm	
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Tri-staining Visualization 
 Using a combination of techniques and procedures for staining, tri-stained images 
were produced using MitoRed red for mitochondrial staining, Phalloidin for actin 
cytoskeleton dendritic staining, and Hoescht dye for nuclei staining. Images were taken at 
20x magnification, were overlayed and qualitatively analyzed (Figure 12). Although 
experimental and control groups were unable to both be imaged, the image below 
displays visual overlay between the actin cytoskeleton and mitochondria around the 
nuclei of the cells. The mitochondria, via the red MitoRed staining, are circled around the 
blue nuclei Hoescht staining, while the green actin staining of the cytoskeleton travels 
from the mitochondria (red) to the periphery of the cell. 
 
Figure 12. Tri-stained image of SH-SY5Y cells. Cells were stained with MitoRed for 
mitochondrial visualization, Phalloidin for actin cytoskeleton visualization and Hoechst 
dye for nuclei visualization. Qualitatively, the mitochondria (red) surround the periphery 
of the nucleus, while the actin cytoskeleton (green) travel from inwards from the nucleus 
outwards to the cell membrane.  
100µm 
	32 
Oxygen Consumption and BMP-2 Induction  
 Basal respiration, ATP production, maximal respiration rate, spare respiratory 
capacity, non-mitochondrial respiration and proton leak were assessed at Day 4 using the 
Seahorse XF 96 mitochondrial stress test. All parameters assessed in the mitochondrial 
respiration assay where increased in BMP-2 treated cells in comparison to control cells 
(Figure 13). Basal respiration was significantly increased in BMP-2 treated than control 
groups (p=0.031). ATP production was also significantly increased in the BMP-2 treated 
cells compared to the control cells (p=0.010). However, there was no significant 
difference between the BMP-2 and control cells in spare respiratory capacity (p=0.604). 
Non-mitochondrial oxygen consumption was significantly increased in BMP-2 treated 
than the control groups (p=0.041). Lastly, there was no significant difference in proton 
leak between experimental BMP-2 treated groups and control BMP- groups (p= 0.165) 
(Figure 14). 
 
Figure 13. Oxygen consumption rate (OCR) assessment as in indicator for 
mitochondrial respiration over time. Performed using Seahorse 96 XF mitochondrial 
stress test, mitochondrial respiration indicated by oxygen consumption rate (OCR) was 
increased in BMP-2 groups than the control (BMP-) groups throughout the length of 
Seahorse 96XF stress test. Data were normalized to DNA content using PicoGreen 
fluorescence assay.  
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Figure 14.  Oxygen consumption rate (OCR) measurements by parameter. 
Parameters measured using Seahorse 96 XF stress test (basal respiration, ATP 
production, spare respiratory capacity, non-mitochondrial oxygen consumption, maximal 
respiration and proton leak) were increased with BMP-2 conditions than in control 
(BMP-) conditions. Basal respiration, ATP production, non-mitochondrial oxygen 
consumption and maximal respiration were significantly increased in BMP-2 conditions.  
All values were normalized to DNA content using PicoGreen fluorescent DNA assays.    
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DISCUSSION 
 
 This study explored the function of BMP-2 on oxidative metabolism and dendritic 
development in a neural cell line. The goal of this study was to assess the measurements 
of oxidative phosphorylation normalized to DNA content with relation to BMP-2 based 
on the hypothesis that BMP-2 induces upregulation of oxidative metabolism. 
Investigation of BMP-2 was performed by culturing SH-SY5Y neural cells with and 
without BMP-2 (+/- BMP-2) and performing necessary DNA assays, fluorescent imaging 
and metabolic assays.  
 
BMP-2 Decreases DNA Content  
 The BMP-2 treated SH-SY5Y neural cells had less DNA content than cells 
cultured without BMP-2. This result was consistent with previous findings that showed 
that BMP-2 induced differentiation and decreased proliferation in these cells. These 
results are consistent with current research on BMP-2 in that dopaminergic neurons 
treated with BMP-2 had significantly decreased MTT assay fluorescence, which 
researchers denoted was indicative of an increase in differentiation (Hegarty et al. 2013). 
Because MTT assay evaluates mitochondria content and showed lower absorbance 
compared to controls it is unclear since BMP-2 also effects mitochondria activity if MTT 
is the ideal surrogate for cell number. Additionally, Nakumara et al. (2003) counted 
viable SH-SY5Y cells in the presence or absence of BMP-2 at day 2, day 4, and day 6 
and showed that cells treated with BMP-2 proliferated at a slower rate compared to non-
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treated cells. This suggests that BMP-2 induces differentiation and has a role in cellular 
metabolism involving the arrest of proliferation.   
Moreover, experimental studies performed using non-neural cell lines, also 
experienced significant difference in DNA content between cells treated with BMP-2 and 
those without. In a recent study, Bui (2018) used C3H10T1/2 mesenchymal stem cells 
(MSCs) to assess BMP-2 involvement in MSC differentiation and proliferation as well as 
address growth with phosphate and ascorbic acid availability. Bui showed that BMP-2 
treated MSCs has significantly lower amounts of DNA content than control groups 
regardless of phosphate or ascorbic treatment. While decreased DNA content in BMP-2 
treated cells is suggestive of decreases in proliferation and increases in differentiation 
compared to controls, further investigation into BMP-2’s signaling and its interaction 
with growth factors could provide mechanisms into these changes in cellular growth.   
 
BMP-2 Increases Dendritic Interactions 
When analyzing dendritic interactions in SH-SY5Y cells, the BMP-2 treatment 
showed a slight increase in the proportion of multiple dendritic interactions compared to 
the non-treated control cells. Although these results are not significant, these findings are 
consistent with previous research that showed BMP-2 induced SH-SY5Y neuronal 
differentiation resulting in neurite extension (Hegarty et al. 2013). While these changes in 
dendritic properties, supplemented with previous research regarding decreased DNA 
content with BMP-2 treatment in a variety of cells types, suggests that BMP-2 plays a 
more generalized role inducing differentiation and decreasing proliferation.  
	36 
BMP-2 Treatment Results in Increased Oxidative Respiration  
 Treatment of BMP-2 in SH-SY5Y cells was associated with increased oxidative 
metabolism. This is consistent with previous studies that showed articular chondrocytes 
(ACs) of patients with osteoarthritis treated with BMP-2 treatment resulting in increased 
mitochondrial oxidative metabolism. Using the Seahorse XF mitochondrial stress test 
researchers showed that BMP-2 treatment significantly increased oxygen consumption 
rate (OCR), specifically in regards to both basal and maximal respiration, in ACs with 
limited effect of glycolytic protein expression (Wang et al. 2018). Although we did not 
analyze changes in protein expression, all parameters of oxidative metabolism given by 
measures of OCR in the SH-SY5Y cell line did increase with BMP-2 treatment.  
While metabolic markers correlated with oxidative phosphorylation, such as 
protein measures of the TCA cycle were not conducted in relation to changes in oxidative 
metabolism in this study, recent research studies showed that there was an increase in 
oxidative metabolism markers with BMP-2 treatment.  Klontzas et al. (2017) performed a 
metabolomics analysis to evaluate the metabolism of MSCs undergoing osteogenesis 
with the addition of osteogenic agents, such as BMP-2, in comparison with non-
differentiated MSCs and primary osteoblasts. BMP-2 treated cells had a metabolic state 
that differed from non-treated cells. Moreover, when BMP-2 treated cells were assessed 
for metabolite concentrations, treated cells had significantly increased glucose, TCA 
cycle intermediates (fumarate and citrate) and glutamate as compared to undifferentiated 
MSCs and primary osteoblasts (Klontzas et al. 2017). Consistent with our research study, 
treatment of BMP-2 did show increases in oxidative phosphorylation. While it is known 
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that BMP-2 induces MSC differentiation, the mechanisms of BMP-2 altering metabolic 
activity as well as upregulation of mitochondrial metabolites need additional 
investigation. Further analysis of mitochondrial and nuclear genetics involved with the 
treatment of BMP-2 might allow for the identification of an underlying mechanism in 
which BMP-2 increases oxidative respiration and metabolites known to be involved in 
the upregulation of mitochondrial activity.  
 
Limitations and Future Discussions 
 Limitations with this study include sample size and cell viability, both of which 
were commonly problematic. The fluorescent staining stocks which initially required the 
use of Phosphate-Buffered Saline (PBS) were performed using neuron cell growth 
medium due to the cell’s tendency to ball up or dislodge from the plate reducing cell 
viability and quantitative amount in assays. Due to this issue, Seahorse normalization 
occurred without proper number of replicates resulting in significant values based off 
minimal replicates. Follow up experiments regarding Seahorse 96 XF mitochondrial 
stress tests should be performed in order to complement the results of this study. In this 
regard, future studies using SH-SY5Y cells should be grown and assayed, when 
appropriate, in growth medium. Additionally, Seahorse assays and therefore subsequent 
PicoGreen DNA assays should be performed at a higher seeding density to allow for the 
possibility of cells dying or dislodging from wells.  
Quantification of dendrites and nuclei had limitations. Quantification was difficult 
due to the growth patterns of SH-SY5Y cells that bunch and the edge effect, where cells 
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primarily grew near the edge of the wells. Samples had to be removed from 
randomization during manual counting for dendritic interaction and visualization of 
mitochondria when regions where dendrites had become tangled or where nuclei seemed 
to be too bunched to allow for separation. Further studies pursuing fluorescence imaging 
should take note of the growth pattern associated with SH-SY5Y cells in wells and 
account for this by plating at a relatively low seeding density.  
While this research study assessed oxidative phosphorylation upregulation by 
measuring oxygen consumption rate with and without BMP-2, genetic analysis would 
allow for identification of methodology and mechanism. Future investigations should 
include the assessment of mitochondrial DNA (mDNA) which could evaluate changes in 
mitochondria amount in relation to changes in oxidative metabolism. In addition, using 
MitoRed and greater magnification to not only locate but also quantify mitochondria 
could bring insight into the mitochondrial mechanisms behind increases in oxidative 
metabolism with BMP-2 treatment.  
Furthermore, although this experiment assessed oxidative metabolism alterations, 
investigating changes in glycolytic activities could allow greater characterization of the 
role of BMP-2 in metabolism. Future studies could measure the extracellular acidification 
rate (ECAR) using the Seahorse XF Glycolysis Stress Test, as ECAR allows for the 
quantification of acidic glycolytic end products. Furthermore, assessing OCR/ECAR, that 
is, the ratio between oxidative metabolism and glycolytic metabolism, would provide a 
more complete analysis of changes that occur in metabolism with BMP-2 treatment.  
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CONCLUSION 
 In this study, we attempted to explore the relationship between BMP-2 and 
oxidative respiration, and assess the properties associated with changes in metabolic 
parameters including morphological cell changes representative in dendrite interaction as 
well as DNA content. Our findings suggest BMP-2 may play a role in metabolic shifts 
associated with increased differentiation in SH-SY5Y cells. While BMP-2 has been well 
studied in mesenchymal stem cell differentiation and proliferation, through the utilization 
of the neural cell line, SH-SY5Y, this research suggests a more generalized functionality 
of BMP-2 in upregulation of oxidative metabolism and differentiation non-specific to 
bone and chondrocyte cell lineage. Understanding this unique relationship of BMP-2’s 
importance with both differentiation and metabolism is imperative in understanding the 
potential effects that BMP-2 can play in development and regeneration of cells and 
tissues.  
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